Krsnaa Diagnostics (Small Cap) Share Target 2026, 2027 To 2035
|
Krsnaa Diagnostics Limited |
|||
|
Price: ₹538.75 (0.83%) | ||
| 52 Week Low: ₹515.00 52 Week High: ₹894.40 |
|||
| Market Capital: 1,983.46 Crore (Small-cap) | |||
| Healthcare -> Diagnostics & Research | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Krsnaa Diagnostics Share Price Target For 2026
- 1.1.1: Krsnaa Diagnostics Share Price Target Table For 2026
- 1.1.2: Short-Term Technical Outlook
- 1.2: Krsnaa Diagnostics Share Price Target For 2027
- 1.2.1: Krsnaa Diagnostics Share Price Target Table For 2027
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Krsnaa Diagnostics Share Price Target Chart and Table From 2026, 2027, 2028 to 2035
- 3: Krsnaa Diagnostics Brief Company Overview
- 4: Krsnaa Diagnostics Financial Performance
- 4.0.1: Is Krsnaa Diagnostics A Good Buy For Long Term?
Krsnaa Diagnostics, a Small Cap company in the Diagnostics & Research Industry showing 19.9% quarterly revenue growth with 10.2% profit margin.
To predict the Krsnaa Diagnostics's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Krsnaa Diagnostics Share Price Target For 2026
The line chart displays the monthly closing prices of Krsnaa Diagnostics with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Krsnaa Diagnostics shares in 2026, see the table below.
Krsnaa Diagnostics Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 575.54 (+6.82%) | Trend: SMA50 |
| 2026 Target 2 | 569.27 (+5.66%) | Volatility: BB Upper |
| 2026 Target 1 | 539.89 (+0.21%) | Trend: EMA9 |
| Current Price | 538.75 | Krsnaa Diagnostics's share price as of 15 Jun 2026 |
| Stop Loss 1 | 525.91 (-2.39%) | Volatility: BB Lower |
| Stop Loss 2 | 520.31 (-3.43%) | 98.60% Weekly Fib Retrace |
| Stop Loss 3 | 484.56 (-10.06%) | Volatility: ATR S1 |
Short-Term Technical Outlook
Current Technical Position: Krsnaa Diagnostics is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 50-day moving average at ₹575.54 serves as the nearest technical reference point.
Historical Returns: 3-month: -10.16% | 6-month: -28.11% | 1-year: -21.15%
Krsnaa Diagnostics Share Price Target For 2027
The line chart displays the monthly closing prices of Krsnaa Diagnostics with a black line. The green line shows three potential target prices for 2027, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Krsnaa Diagnostics shares in 2027, see the table below.
Krsnaa Diagnostics Share Price Target Table For 2027
| Level | Value | Analysis |
|---|---|---|
| 2027 Target 3 | 575.54 (+6.82%) | Trend: SMA50 |
| 2027 Target 2 | 569.27 (+5.66%) | Volatility: BB Upper |
| 2027 Target 1 | 539.89 (+0.21%) | Trend: EMA9 |
| Current Price | 538.75 | Krsnaa Diagnostics's share price as of 15 Jun 2026 |
| Stop Loss 1 | 525.91 (-2.39%) | Volatility: BB Lower |
| Stop Loss 2 | 520.31 (-3.43%) | 98.60% Weekly Fib Retrace |
| Stop Loss 3 | 484.56 (-10.06%) | Volatility: ATR S1 |
Long-Term Technical Outlook
52-Week Range Analysis: Krsnaa Diagnostics is currently trading near its 52-week low of ₹515, indicating potential value opportunity.
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -21.15% | 3-year: -7.7% | 5-year: -42.36%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Krsnaa Diagnostics Share Price Target Chart and Table From 2026, 2027, 2028 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹538.75 | ||
| 2026 | ₹565.51 | +4.9670533642691% | ₹573.99 |
| 2027 | ₹569.31 | +0.67195982387579% | ₹577.85 |
| 2028 | ₹552.55 | -2.9439145632432% | ₹560.84 |
| 2029 | ₹593.41 | +7.3948058999186% | ₹602.31 |
| 2030 | ₹608.57 | +2.5547260747207% | ₹617.70 |
| 2031 | ₹618.86 | +1.6908490395517% | ₹628.14 |
| 2032 | ₹588.40 | -4.9219532689138% | ₹597.23 |
| 2033 | ₹547.65 | -6.925560842964% | ₹555.86 |
| 2034 | ₹524.40 | -4.2454122158313% | ₹532.27 |
| 2035 | ₹503.87 | -3.9149504195271% | ₹511.43 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Krsnaa Diagnostics Brief Company Overview
Krsnaa Diagnostics Limited: A Leading Provider of Diagnostic Services in India Established in 2010 and headquartered in Pune, India, Krsnaa Diagnostics Limited has made a name for itself in the healthcare industry. The company offers a comprehensive range of diagnostic...
services, including radiology, pathology/clinical laboratory, and tele-radiology. Krsnaa Diagnostics operates through a network of approximately 2,850 centers across 15 states and 2 Union Territories in India. The company's commitment to delivering accurate and timely diagnostic services has earned it a strong reputation among hospitals, medical colleges, and community health centers. Key Products and Services: Radiology, pathology/clinical laboratory, tele-radiology Market Presence: 2,850 centers across 15 states and 2 Union Territories in India Established: 2010Krsnaa Diagnostics Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 2,954.51 Crore | Market valuation of Krsnaa Diagnostics's shares. |
| Revenue (TTM) | 681.17 Crore | Total revenue generated by Krsnaa Diagnostics over the past twelve months. |
| Net Income (TTM) | +69.21 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 14.59% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 10.16% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+19.9% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
+86.7% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
25.7 | Company's total debt divided by total shareholder equity. |
| Total Debt | 216.08 Crore | Sum of Krsnaa Diagnostics's current & long-term financial obligations. |
| Total Cash | 62.62 Crore | Total amount of liquid funds available to Krsnaa Diagnostics. |
| Beta | -0.17 | Beta is less than 1 indicating that the Krsnaa Diagnostics's price is less volatile than the market. |
Is Krsnaa Diagnostics A Good Buy For Long Term?
No valid response content found
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
